Citigroup’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-2,914
| Closed | -$8K | – | 5790 |
|
2021
Q1 | $8K | Sell |
2,914
-5,186
| -64% | -$14.2K | ﹤0.01% | 5120 |
|
2020
Q4 | $20K | Buy |
8,100
+6,393
| +375% | +$15.8K | ﹤0.01% | 4637 |
|
2020
Q3 | $4K | Sell |
1,707
-3,333
| -66% | -$7.81K | ﹤0.01% | 4810 |
|
2020
Q2 | $19K | Sell |
5,040
-5,289
| -51% | -$19.9K | ﹤0.01% | 4304 |
|
2020
Q1 | $20K | Buy |
10,329
+3,062
| +42% | +$5.93K | ﹤0.01% | 4378 |
|
2019
Q4 | $15K | Buy |
7,267
+4,934
| +211% | +$10.2K | ﹤0.01% | 4602 |
|
2019
Q3 | $5K | Sell |
2,333
-8,168
| -78% | -$17.5K | ﹤0.01% | 4814 |
|
2019
Q2 | $33K | Buy |
10,501
+9,676
| +1,173% | +$30.4K | ﹤0.01% | 4352 |
|
2019
Q1 | $4K | Buy |
+825
| New | +$4K | ﹤0.01% | 4916 |
|
2018
Q3 | – | Sell |
-30,502
| Closed | -$183K | – | 5185 |
|
2018
Q2 | $183K | Buy |
30,502
+26,809
| +726% | +$161K | ﹤0.01% | 3020 |
|
2018
Q1 | $32K | Buy |
3,693
+1,889
| +105% | +$16.4K | ﹤0.01% | 4004 |
|
2017
Q4 | $14K | Buy |
1,804
+1,736
| +2,553% | +$13.5K | ﹤0.01% | 4391 |
|
2017
Q3 | $0 | Sell |
68
-47,173
| -100% | – | ﹤0.01% | 4951 |
|
2017
Q2 | $338K | Buy |
+47,241
| New | +$338K | ﹤0.01% | 2648 |
|
2016
Q2 | – | Sell |
-5
| Closed | – | – | 5410 |
|
2016
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 5719 |
|